Quality of Life in Patients with Multiple Myeloma
![]() |
Jo, Kwan-Suk
(Seoul St. Mary's Hospital, The Catholic University of Korea)
Ban, Ja-Young (Seoul St. Mary's Hospital, The Catholic University of Korea) Yoon, Jee-Yeon (Seoul St. Mary's Hospital, The Catholic University of Korea) Kook, Seung-Hye (Seoul St. Mary's Hospital, The Catholic University of Korea) Yoon, Hyun-Sun (Seoul St. Mary's Hospital, The Catholic University of Korea) Yoo, Yang-Sook (College of Nursing, The Catholic University of Korea) |
1 | Kumar S. Treatment of newly diagnosed multiple myeloma: advances in current therapy. Medical Oncology. 2010;27(Suppl 1):S14-24. http://dx.doi.org/10.1007/s12032-009-9370-1 DOI |
2 | Bilotti E, Faiman BM, Richards TA, Tariman JD, Miceli TS, Rome SI. Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the international myeloma foundation nurse leadership board. Clinical Journal of Oncology Nursing. 2011;15(4):5-8. http://dx.doi.org/10.1188/11.s1.cjon.5-8 DOI |
3 | Smith D, Yong K. Multiple myeloma. British Medical Journal. 2013;346:3863. http://dx.doi.org/10.1136/bmj.f3863 DOI |
4 | Cocks K, Cohen D, Wisloff F, Sezer O, Lee S, Hippe E, et al. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma. European Journal of Cancer. 2007;43(11):1670-8. http://dx.doi.org/10.1016/j.ejca.2007.04.022 DOI |
5 | Palumbo A, Attal M, Roussel M. Shifts in the therapeutic paradigm for patients newly diagnosed with multiple myeloma: maintenance therapy and overall survival. Clinical Cancer Research. 2011;17(6):1253-63. http://dx.doi.org/10.1158/1078-0432.ccr-10-1925 DOI |
6 | Comert M, Gunes AE, Sahin F, Saydam G. Quality of life and supportive care in multiple myeloma. Turkish Journal of Haematology. 2013;30(3):234-46. http://dx.doi.org/10.4274/Tjh.2012.0192 DOI |
7 | Jordan K, Proskorovsky I, Lewis P, Ishak J, Payne K, Lordan N, et al. Effect of general symptom level, specific adverse events, treatment patterns, and patient characteristics on health-related quality of life in patients with multiple myeloma: results of a European multicenter cohort study. Supportive Care in Cancer. 2014;22(2):417-26. http://dx.doi.org/10.1007/s00520-013-1991-4 DOI |
8 | Osborne TR, Ramsenthaler C, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ. What issues matter most to people with multiple myeloma and how well are we measuring them? A systematic review of quality of life tools. European Journal of Haematology. 2012;89(6):437-57. http://dx.doi.org/10.1111/ejh.12012 DOI |
9 | Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation. Biology of Blood and Marrow Transplantation. 2009;15(1):12-20. http://dx.doi.org/10.1016/j.bbmt.2008.09.023 DOI |
10 | Khalafallah A, McDonnell K, Dawar HU, Robertson I, Woods D. Quality of life assessment in multiple myeloma patients undergoing dose-reduced tandem autologous stem cell transplantation. Mediterranean Journal of Hematology and Infectious Disease. 2011;3(1):e2011057. http://dx.doi.org/10.4084/mjhid.2011.057 DOI |
11 | Sonneveld P, Verelst SG, Lewis P, Gray-Schopfer V, Hutchings A, Nixon A, et al. Review of health-related quality of life data in multiple myeloma patients treated with novel agents. Leukemia. 2013;27(10):1959-69. http://dx.doi.org/10.1038/leu.2013.185 DOI |
12 | Corso A, Mangiacavalli S, Cocito F, Pascutto C, Ferretti VV, Pompa A, et al. Long term evaluation of the impact of autologous peripheral blood stem cell transplantation in multiple myeloma: a cost-effectiveness analysis. The Public Library of Science One. 2013;8(9):e75047. http://dx.doi.org/10.1371/journal.pone.0075047 DOI |
13 | Stead ML, Brown JM, Velikova G, Kaasa S, Wisloff F, Child JA, et al. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life. British Journal of Haematology. 1999;104(3):605-11. DOI |
14 | Kontodimopoulos N, Samartzis A, Papadopoulos AA, Niakas D. Reliability and validity of the Greek QLQ-C30 and QLQ-MY20 for measuring quality of life in patients with multiple myeloma. The Scientific World Journal. 2012;2012:842-67. http://dx.doi.org/10.1100/2012/842867 DOI |
15 | Kim HS, Yi MS. Factors influencing quality of life in multiple myeloma. Asian Oncology Nursing. 2015;15(1):9-17. DOI |
16 | Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mcfadden ET, et al. Toxicity and response criteria of the eastern cooperative oncology group. American Journal of Clinical Oncology. 1982;5(6):649-55. DOI |
17 | Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47(1):207-14. DOI |
18 | Jung JY, So HS, Hong JE, Chea MJ, Han KH. Related factors to quality of life among hospitalized cancer patients undergoing chemotherapy. Asian Oncology Nursing. 2012;12(1):84-91. DOI |
19 | Jung KH, Kim KH, Gwak YH. Quality of life in colorectal cancer patients according to the severity of symptom clusters classification. Asian Oncology Nursing. 2014;14(2):74-83. DOI |
20 | Kim JH, Choi KS, Kim T, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Asian Oncology Nursing. 2011;11(3):254-62. |
21 | Yang JY, Lee MS. Factors influencing quality of life in thyroid cancer patients with thyroidectomy. Asian Oncology Nursing. 2015;15(2):59-66. DOI |
22 | Kim KD, Jang HJ. Effect of pain, sleep, disturbance and fatigue on the quality of life in patients with pancreatic cancer undergoing chemotherapy. Asian Oncology Nursing. 2012;12(2):117-24. DOI |
23 | Can G, Demir M, Erol O, Aydiner A. A comparison of men and women's experiences of chemotherapy-induced alopecia. European Journal of Oncology Nursing. 2013;17(3):255-60. http://dx.doi.org/10.1016/j.ejon.2012.06.003 DOI |
24 | Goodwin JA, Coleman EA, Sullivan E, Easley R, McNatt PK, Chowdhury N, et al. Personal financial effects of multiple myeloma and its treatment. Cancer Nursing. 2013;36(4):301-8. http://dx.doi.org/10.1097/NCC.0b013e3182693522 DOI |
25 | Kirchhoff AC, Leisenring W, Syrjala KL. Prospective predictors of return to work in the 5 years after hematopoietic stem cell transplantation. Journal of Cancer Survivorship: Research and Practice. 2010;4(1):33-44. http://dx.doi.org/10.1007/s11764-009-0105-2 DOI |
26 | Song BE, Kang HR, Kim KS. Quality of life in patients with hematopoietic stem cell transplantation. Asian Oncology Nursing. 2008;8(1):40-9. |
27 | Jo OH, Park LH, Yang NY, Hwang KH. Mood state, interaction anxiety and quality of life of cancer patients with chemotherapy-induced alopecia. Asian Oncology Nursing. 2013;13(4):193-200. DOI |
28 | Faiman B. Clinical updates and nursing considerations for patients with multiple myeloma. Clinical Journal of Oncology Nursing. 2007;11(6):831-40. http://dx.doi.org/10.1188/07.cjon.831-840 DOI |
29 | Kim HY, Kang JH, Song JE, Yoon HJ. Chemotherapy-induced peripheral neuropathy and quality of life in breast cancer patients. Asian Oncology Nursing. 2013;13(4):222-30. DOI |
30 | Kurtin S, Faiman B. The changing landscape of multiple myeloma: implications for oncology nurses. Clinical Journal of Oncology Nursing. 2013;17(Suppl):7-11. http://dx.doi.org/10.1188/13.cjon.s2.7-11 DOI |
![]() |